Eltrombopag with Immunosuppressive Therapy Shows Promising Safety in Pediatric Severe Aplastic Anemia – Phase 2 ESCALATE Trial Results
Blood Journals Portfolio shared a post on X:
“Eltrombopag’s pharmacokinetics profile was similar to that seen in patients with immune thrombocytopenia, with no unexpected safety signals.”
Title: Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial
Authors: Akiko Shimamura, Alexey Maschan, Carolyn Bennett, Sujith Samarasinghe, Jason E. Farrar, Chi-kong Li, Nongnuch Sirachainan, Bunchoo Pongtanakul, Patcharee Komvilaisak, Ludmila Zubarovskaya, Jennifer A. Rothman, Kelly Walkovich, Taizo A. Nakano, Alison A. Bertuch, Anabela Ferrao, Rukhmi Bhat, Rabi Hanna, Kathleen Overholt, Jessica Boklan, Tze Fang Wong, Qinxia Wang, Patrick Urban, Brigitte Strahm, Winfred Wang, Adrianna Vlachos, David A. Williams
Read the full article here.
All the latest news featured in Hemostasis Today.
-
Feb 2, 2026, 16:52Aravind Palraj: Young Stroke is Never Just Stroke
-
Feb 2, 2026, 16:48Seyed Mohsen Jahromi Moghadam: Antithrombotic Therapy After Transcatheter Structural Heart Interventions
-
Feb 2, 2026, 16:45Shashank Joshi: Switching Among Oral Anticoagulants
-
Feb 2, 2026, 16:40Zeinab Mubarak: How do Women Benefit from Menstrual Blood?
-
Feb 2, 2026, 16:23Ignacio Diaz Lorenzo: Reflecting on the Management of Acute Pulmonary Embolism
-
Feb 2, 2026, 16:18Tareq Abadl: Persistent Anti-β2GPI IgG Is Not a Coincidence – It’s Pathology
-
Feb 2, 2026, 16:06Christian Heiss։ When Diabetes and PAD Overlap, Cardiovascular and Limb Risks Rise
-
Feb 2, 2026, 16:02Shiny K. Kajal: Platelet Transfusion Is a Therapy – Not a Reflex
-
Feb 2, 2026, 15:37Rana Saifi: An Exciting Time for the Bleeding Disorders Community